MedTrace Logo

Revision Total Hip Replacement Arthroplasty and Hematologic Variables

NCT02951741 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2017-10-11

No results posted yet for this study

Summary

Revision total hip replacement arthroplasty is a surgery having intra- and postoperative substantial blood loss. The investigators will investigate the relationship between the various hematologic variables and postoperative bleeding volume.

Conditions

  • Avascular Necrosis of Hip
  • Degenerative Hip Joint Disease

Interventions

OTHER

RTHRA group

hematologic variables measurement in patients undergoing revision total hip replacement

Sponsors & Collaborators

  • Seoul National University Bundang Hospital

    lead OTHER

Principal Investigators

  • Hyo-Seok Na, MD, PhD · Seoul National University Bundang Hospital

Eligibility

Min Age
20 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2017-02-28
Completion
2017-02-28

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02951741 on ClinicalTrials.gov